Loading stock data…
BioNexus Gene Lab Corp (BGLC)
$1.51-0.03 (-1.95%)
Market ClosedLast close Jul 24
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
BioNexus Gene Lab Corp. in the Basic Materials sector is trading at $1.51 with a market capitalization of $6M. The stock is currently near its 52-week low of $1.07, remaining 50.8% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 18 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 18) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $22,842↓ | $483,760↓ | $2.54M↑ | $2.26M↑ | $2.14M |
| Gross Profit | -$790↑ | -$3,983↓ | $377,685↑ | $368,022↑ | $343,493 |
| Operating Income | -$571,433↑ | -$1.03M↓ | -$810,269↓ | -$699,993↓ | -$616,188 |
| Net Income | -$543,575↑ | -$1.04M↓ | -$708,991↓ | -$616,172↑ | -$623,327 |
Peer Comparison
Fundamentals
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other c...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.97M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-35.89%
Volume
Today's trading volume
4,752